INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Medistem,
Inc. and Its Board of Directors in Connection with the Sale of the Company
to Intrexon Corporation
NEW YORK -- December 20, 2013
Levi & Korsinsky is investigating the Board of Directors of Medistem, Inc.
(“Medistem” or “the Company”) (OTCQB:MEDS) for possible breaches of fiduciary
duty and other violations of state law in connection with the sale of the
Company to Intrexon Corporation (“Intrexon”).
Click here to learn more about the action http://zlk.9nl.com/medistem-meds/,
or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of transaction, Medistem shareholders will receive $0.27 in
cash and $1.08 worth of Intrexon common stock for each share of Medistem stock
they own. The transaction has a total approximate value of $26 million. The
investigation concerns whether the Medistem Board of Directors breached their
fiduciary duties to stockholders by failing to adequately shop the Company
before agreeing to enter into this transaction, and whether Intrexon is
underpaying for Medistem shares.
If you own Medistem common stock and wish to obtain additional information,
please contact Joseph E. Levi, Esq. either via email at email@example.com or by
telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit
Levi & Korsinsky is a national firm with offices in New York, New Jersey,
Connecticut and Washington D.C. The firm’s 26 attorneys have extensive
expertise in prosecuting securities litigation involving financial fraud,
representing investors throughout the nation in securities and shareholder
lawsuits. For more information, please feel free to contact any of the
attorneys listed below. Attorney advertising. Prior results do not guarantee
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
Toll Free: 877-363-5972
Press spacebar to pause and continue. Press esc to stop.